Dr. Ashani T. Weeraratna on Aging and its Effects on How Melanoma Progresses and is Treated
Ashani T. Weeraratna, PhD, discusses the similarities in treatment between younger and older patients with melanoma. She says this lack of differentiation between treatment regimens could pose a problem in the future. One such issue is that older patients tend to react less well to treatments like vemurafenib.
Ashani T. Weeraratna, PhD, associate professor, Tumor Microenvironment and Metastasis Program, The Wistar Institute, discusses the similarities in treatment between younger and older patients with melanoma. She says this lack of differentiation between treatment regimens could pose a problem in the future. One such issue is that older patients tend to react less well to treatments like vemurafenib.
Weeraratna says in order to better treat older patients with melanoma, medical professional should not resort to dose lowering. She also adds that finding reliable molecular targets in older patients.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
